Shaymaa spoke to us about the cell culture industry, including Cho-K1 cell line. Shaymaa will be speaking about the Comparison Of Bolus And Continuous Feed Strategies For A Cho-K1 Cell Lineon day 2 of the 6th Annual Cell Culture & Bioprocessing Congress.

Dylan Jones joined Genzyme in 2004 as a PAT Scientist, developing in-line spectroscopic assays for API manufacturing. As Principal Scientist, he now leads a team of scientists who design, develop, and implement process analytics and automation into (bio) manufacturing processes.
Dylan spoke to us about the analytics side of the bioprocessing industry, including how he thinks Processing Analytical Testing (PAT) can help to drive innovation. Dylan will be speaking about the use of spectroscopy on the first day of the 4th Annual Cell Culture & Bioprocessing Congress.

Nicolas Mermod is Professor of Biotechnology at the Faculty of Biology and Medicine at the University of Lausanne. Nic heads the Laboratory for Molecular Biotechnology at the Center for Biotechnology UNIL-EPFL, which has gained global recognition in the field of the control of gene expression in biotechnology by publishing in peer reviewed renowned journals.
Besides his scientific publications, Nic has authored a number of patents on epigenetic regulatory elements and gene transfer. We spoke to Nic about the potential impact Next Generation Sequencing (NGS) could have for the biologics and biotech industry.

In 2014 we spoke to Lance Wong, Director of CMC and Product Development, Bavarian Nordic in the lead up the last Cell Culture & Bioprocessing Congress.

Before becoming Director of CMC and Product Development, Lance was Director of Process Development at Bavarian Nordic. In this role Lance was responsible for a number of key projects, including the freeze-drying development program funded by the US government, and before this he held key positions in the process value chain for biologics, from early stage through to licensure. Lance spoke at the Cell Culture Congress in 2014, and kindly agreed to share his views on the advances in cell culture technology and also the most pressing vaccine development challenges with us.